Economic evaluation of human papillomavirus vaccination in the United Kingdom

Jit, M; Choi, YH; Edmunds, WJ; (2008) Economic evaluation of human papillomavirus vaccination in the United Kingdom. BMJ, 337. a769. ISSN 0959-535X DOI: https://doi.org/10.1136/bmj.a769

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmj.a769

Abstract

Item Type Article
Keywords Adolescent, Age Distribution, Child, Colposcopy/economics, Condylomata Acuminata/economics/prevention & control, Cost-Benefit Analysis, Female, Great Britain, Humans, Male, Mass Screening/economics, Papillomavirus Infections/economics/*prevention & control, Papillomavirus Vaccines/*economics, Patient Satisfaction, Quality-Adjusted Life Years, Regression Analysis, Uterine Cervical Neoplasms/economics/*prevention & control/virology, Vaccination/*economics, Adolescent, Age Distribution, Child, Colposcopy, economics, Condylomata Acuminata, economics, prevention & control, Cost-Benefit Analysis, Female, Great Britain, Humans, Male, Mass Screening, economics, Papillomavirus Infections, economics, prevention & control, Papillomavirus Vaccines, economics, Patient Satisfaction, Quality-Adjusted Life Years, Regression Analysis, Uterine Cervical Neoplasms, economics, prevention & control, virology, Vaccination, economics, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin, AdolescentAge DistributionChildColposcopy/economicsCondylomata Acuminata/economics/prevention & controlCost-Benefit AnalysisFemaleGreat BritainHumansMaleMass Screening/economicsPapillomavirus Infections/economics/*prevention & controlPapillomavirus Vaccin
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Research Centre Vaccine Centre
PubMed ID 18640957
ISI 258561100031
Related URLs

Share

Download

Filename: bmj.a769.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar